Yahoo Finance

Mikart and Nano PharmaSolutions Announce Positive Interim Data from NT-301 Phase 1 Trial and Expansion of NanoTransformer® Manufacturing Capabilities

ATLANTA and SAN DIEGO, Sept. 18, 2025 /PRNewswire/ -- Mikart, LLC, a leading contract development and manufacturing organization (CDMO), and Nano PharmaSolutions, Inc. (NPS), a nanodrug delivery ...
MarketWatch

Mikart and Nano PharmaSolutions Announce Positive Interim Data from NT-301 Phase 1 Trial and Expansion of NanoTransformer(R) Manufacturing Capabilities

The MarketWatch News Department was not involved in the creation of this content. ATLANTA and SAN DIEGO, Sept. 18, 2025 /PRNewswire/ -- Mikart, LLC, a leading contract development and manufacturing ...
Mena FN

Mikart And Nano Pharmasolutions Announce Positive Interim Data From NT-301 Phase 1 Trial And Expansion Of Nanotransformer® Manufacturing Capabilities

(MENAFN- PR Newswire) NT-301, a drug-device combination product manufactured at Mikart's GMP facility in Atlanta, is powered by NanoTransformer® technology, Nano PharmaSolutions' patented nanodrug ...